Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-035308
Filing Date
2025-11-17
Accepted
2025-11-17 09:01:17
Documents
1
Period of Report
2025-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3458
  Complete submission text file 0001437749-25-035308.txt   5192
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 BOSTON MA 02210
Business Address
Winton Matthew (Reporting) CIK: 0001971400 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37942 | Film No.: 251489513